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ABSTRACT
Various liver diseases result in terminal hepatic failure, and
liver transplantation, cell transplantation and artiﬁcial liver
support systems are emerging as effective therapies for
severe hepatic disease. However, all of these treatments are
limitedbyorganorcell resources, sodevelopingasufﬁcient
number of functional hepatocytes for liver regeneration is a
priority. Liver regeneration is a complex process regulated
by growth factors (GFs), cytokines, transcription factors
(TFs), hormones, oxidative stress products, metabolic net-
works, and microRNA. It is well-known that the function of
isolated primary hepatocytes is hard to maintain; when
cultured in vitro, these cells readily undergo dedifferentia-
tion, causing them to lose hepatocyte function. For this
reason, most studies focus on inducing stem cells, such as
embryonicstemcells (ESCs), inducedpluripotentstemcells
(iPSCs), hepatic progenitor cells (HPCs), andmesenchymal
stem cells (MSCs), to differentiate into hepatocyte-like cells
(HLCs) in vitro. In this review, wemainly focus on the nature
of the liver regeneration process and discuss how to main-
tainandenhance invitrohepatic functionof isolatedprimary
hepatocytes or stem cell-derived HLCs for liver regenera-
tion. In this way, hepatocytes or HLCs may be applied for
clinical use for the treatment of terminal liver diseases and
may prolong the survival time of patients in the near future.
KEYWORDS liver regeneration, primary hepatocyte,
stem cell, hepatocyte-like cell, in vitro culture
INTRODUCTION
Viral hepatitis, fatty liver disease, drug-induced liver injury,
liver cirrhosis, hepatic carcinoma, and other liver diseases
can cause acute or chronic liver failure. Approximately 10%
of patients with liver disease succumb to their condition while
waiting for liver sources each year (Kim et al., 2006).
Liver transplantation was once the only therapeutic option
for patients with end stage liver diseases, and its clinical use
was limited due to limited donor availability, surgical injuries,
a high incidence of surgical complications and the high cost
of the treatment (Duan et al., 2013). Later, cell transplanta-
tion and artiﬁcial liver support emerged as effective methods
for compensation of lost liver function and increased the
survival rate of patients; however, these two methods are
also limited by the availability of effective cell sources and
equipment. The inability of hepatocytes to proliferate in vitro
and the severely inadequate supply of hepatocytes due to
donor shortage are still the main problems for primary human
hepatocyte-based treatments. Stem cells have been pro-
posed as an ideal cell source because they have potent self-
renewal, low immunogenicity, and the capacity to differenti-
ate into various cell types. Furthermore, they can generate
unlimited hepatocytes with incomplete function (Sancho-Bru
et al., 2009) that are generally deﬁned as hepatocyte-like
cells (HLCs). HLCs can be derived from multiple stem cell
types, such as embryonic stem cells (ESCs), induced
pluripotent stem cells (iPSCs), hepatic progenitor cells
(HPCs), and mesenchymal stem cells (MSCs). Therefore, it
is crucial to develop robust methods for differentiating stem
cells into mature hepatocytes in vitro for clinical use.
Here, we present an overview of isolated primary hepa-
tocytes and stem cell-derived HLCs used for liver regener-
ation and describe how the in vitro environment in which they
are cultured is continuously being optimized to mimic in vivo
conditions and maintain hepatic function. The main disad-
vantages, histologic origin, 3D, and co-culture environment
for in vitro culture of isolated hepatocytes or stem cell-
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derived hepatocytes were demonstrated in Table 1. Opti-
mization of in vitro culturing of functional hepatocytes will
solve the issues of limited cell numbers and limited function,
and sufﬁcient numbers of functional hepatocytes will be used
to promote liver regeneration directly or indirectly.
NATURE OF LIVER REGENERATION
The liver serves as a major storage site of glycogen and
vitamin A and is one of only a few organs in adults that are
capable of regeneration. Normal mature hepatocytes and
cholangiocytes stay in the G0 phase of the cell cycle, exhibit
a quiescent phenotype and show minimal turnover, but in
response to partial hepatectomy (PH), they can undergo cell
proliferation to compensate for the lost cells, a process
called liver regeneration. However, severe damage caused
by liver diseases can signiﬁcantly diminish the proliferative
ability of these cells and, thus, their liver regeneration ability.
When that is the case, liver tissue transplantation may be
required (Samuel et al., 2011).
Spontaneous liver tissue regeneration (Fujiyoshi and
Ozaki, 2011) is achieved by a complex interactive network
consisting of liver cells (hepatocytes, kupffer cells, sinusoidal
endothelial cells, hepatic stellate cells, and stem cells) and
extrahepatic organs (the thyroid gland, adrenal glands, pan-
creas, duodenum, and autonomic nervous system). Growth
factors (GFs), transcription factors (TFs), cytokines, hor-
mones, oxidative stress products, metabolic networks, and
microRNA are essential for liver regeneration to proceed in an
optimal manner to gain adequate hepatic mass (Mao et al.,
2014). Mitogenic GFs override the G1 restriction point and
promote hepatocytes to transit into S phase. The restoration
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et al., 2011), micro-cavitary
hydrogel (MCG) system (Lau
et al., 2013), type I collagen
and Swiss 3T3 cell sheets
(Nagamoto et al., 2012), multi-
component hydrogel ﬁbers
(Du et al., 2014)
Bone marrow mesenchymal
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(Javed et al., 2014)
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scaffolds (Piryaei et al., 2011),
3D matrixes of poly (ethylene
glycol)-b-poly(l-alanine)
thermogel (Kim et al., 2014),
bioartiﬁcial liver system (Yang
et al., 2013)
Hepatoma-derived C3A cells
(Yang et al., 2013), cystic
ﬁbrosis airway epithelial cells
(Paracchini et al., 2012)
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of liver volume depends on hepatocyte proliferation, which
includes initiation, proliferation, and termination phases.
After PH, more than 100 immediate early genes are acti-
vated by TFs that are latent in the quiescent liver. Interleukin
(IL)-6 (Li et al., 2001), lipopolysaccharide (Cornell et al.,
1990), C3a, and C5a (Strey et al., 2003) can initiate the
cytokine cascade and trigger liver regeneration. Nuclear fac-
tor-kB (Deng et al., 2009), calcitonin gene-related peptide
(Mizutani et al., 2013), caspase recruitment domain-contain-
ing protein 11, zinc ﬁnger protein 490 (Nygard et al., 2012),
and heat shock protein 70 (Wolf et al., 2014) contribute to the
early phase of successful liver regeneration. Pituitary hor-
mone prolactin administration directly or indirectly increases
the number of proliferating cells during the priming stage of
hepatectomy, which causes an increase in the binding activity
of several TFs involved in cell proliferation, liver-speciﬁc dif-
ferentiation, and the maintenance of energetic metabolism
(Olazabal et al., 2009). Furthermore, the process of liver
regeneration involves a general reduction of the levels of
many coagulation cascade proteins (Tatsumi et al., 2011).
Auxiliary mitogens include norepinephrine, vascular
endothelial growth factor, insulin, bile acids, serotonin, com-
plement, leptin, estrogens, ﬁbroblast growth factor (FGF)-1,
FGF-2, and IL-4 are also indispensable for the hepatocyte cell
cycle (DeAngelis et al., 2012; Michalopoulos, 2010). Vitamin
D3 upregulated protein-1 regulates proliferative signaling
during liver regeneration by altering the activation of genes
involved in the extracellular signal-regulated kinase 1/2 and
AKTsignaling pathways (Kwon et al., 2011). Growth hormone
signaling molecules (Zerrad-Saadi et al., 2011) and the tran-
scription factor E2F2 (Delgado et al., 2011) are also key
regulators of the cell cycle. Activation of Notch, a signaling
pathway that mediates lineage segregation during liver
development, is sufﬁcient to reprogram hepatocytes into bil-
iary epithelial cells (Yanger et al., 2013). FGF15 is an
essential mediator of the liver growth promoting effects of bile
acids and is necessary to maintain liver growth homeostasis
(Uriarte et al., 2013). P-element-induced wimpy testis inter-
acting RNAs exert regulatory functions on the cell genome
and transcriptome (Rizzo et al., 2014). Hepatic non-
parenchymal cells play a time-dependent regulatory role
(Nejak-Bowen et al., 2013). Nogo-B, also known as reticulon
4B, promotes liver ﬁbrosis and cirrhosis by facilitating the
TGF-b signaling pathway in activated hepatic stellate cells
(HSCs) and facilitates hepatocyte proliferation and liver
regeneration (Gao et al., 2013). The termination of liver
regeneration is a complex process that is affected by integrin-
mediated signaling. The return of HGF and TGF-b to their
baseline levels (Michalopoulos, 2010) and activation of mito-
gen-activated protein kinase kinase-4 (Wuestefeld et al.,
2013) can cause complete termination of liver regeneration.
IN VITRO CELLS WITH HEPATIC FUNCTION
Liver regeneration can proceed through two different
mechanisms: replacement of lost tissue with cell types of
phenotypic ﬁdelity; and replacement of tissue by activation of
transdifferentiation pathways originating from facultative
stem cells. Liver regeneration is a rapid and well-coordinated
process that requires contributions from multiple cell popu-
lations (Fig. 1).
Primary hepatocytes
The liver is primarily composed of two epithelial cell lineages,
namely hepatocytes and cholangiocytes, which originate
from hepatoblasts during fetal development. Hepatocytes
are the predominant cell type in the liver under nonpatho-
logical conditions. Isolated primary human hepatocytes are
currently the gold standard for in vitro drug screening
because they express the entire complement of hepatic drug
metabolizing enzymes and transporters. In spite of their
proliﬁc growth ability in vivo, attempts to proliferate adult
hepatocytes in vitro have been less successful. It has taken
a long time to optimize the hepatocyte culture conditions to
allow them to grow steadily in vitro.
Once plated in a monolayer, primary hepatocytes typically
undergo progressive dedifferentiation, which is reﬂected at
the level of the drug transporters and the dramatic loss in the
phenotypic characteristics of the cells. Speciﬁcally, hepato-
cytes and liver sinusoidal endothelial cells dedifferentiate
within 72 h when cultured as monolayers in vitro. Conven-
tional approaches to counteract this dedifferentiation aim at
reestablishing the natural hepatocyte microenvironment
in vitro and include reintroduction of an extracellular matrix
(ECM) backbone (Skardal et al., 2012), addition of differen-
tiation promoting soluble compounds to the culture medium,
and boosting of homotypic hepatocyte interactions or
cocultivation of hepatocytes with other cell types. However,
the use of this approach is limited by the availability of
reproducible sources of hepatocytes.
The ability of EGF to induce DNA synthesis in primary
hepatocytes was ﬁrst demonstrated in 1976. Thereafter,
many researchers have tried to determine the essential
factors for triggering hepatic regeneration. E-cadherin is
required for hepatocyte spheroid formation and may be
responsible for protecting hepatocytes from a novel form of
caspase-independent cell death (Luebke-Wheeler et al.,
2009). Culturing of rat liver sinusoidal endothelial cells in a
layered three-dimensional conﬁguration, with the layers
separated by a chitosan-hyaluronic acid polyelectrolyte
multilayer, resulted in enhanced heterotypic cell-cell inter-
actions, which led to improvements in hepatocyte function
(Kim and Rajagopalan, 2010). PuraMatrix, a well-deﬁned
synthetic peptide that can self-assemble into an interweav-
ing nanoﬁber scaffold to form a hydrogel, is an attractive
system for generating hepatocyte spheroids that quickly
restore liver function after seeding (Wang et al., 2008). More
recently, hepatocytes sandwiched between matrigel layers
were reported to have stable function. Despite their advan-
tages, collagen and matrigel sandwich cultures do not pro-
vide the complex multi-cellular environment found in vivo,
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and co-cultures do not mimic the layered liver architecture
(Sellaro et al., 2010). Current techniques that maintain
hepatocellular function in vitro with different biomaterials and
geometries exhibit a low cell density and functional capacity
per unit volume.
Stem cell-derived hepatocytes
Stem cells have the potential for numerous biomedical
applications, including therapeutic cell replacement to repair
damaged body organs, as tools for studying genetic defects
and testing drugs, and as models for studying cell differen-
tiation and early development. HLCs can be derived from
ESCs (Subramanian et al., 2014), iPSCs (Amimoto et al.,
2011), HPCs (Wang et al., 2011), and MSCs (Piryaei et al.,
2011), which have the capacity for unlimited proliferation and
multilineage differentiation. However, there are certain
requirements for the generation of HLCs: (a) an unlimited
source of initial cell material is needed to ensure routine
large-scale generation of the required cells; (b) the gener-
ated cultures should be reproducible in terms of their hep-
atic-like functionality; and (c) the established system should
allow for highly efﬁcient selection of hepatocytes.
Embryonic stem cell-derived hepatocytes (ESC-Heps)
ESCs are derived from the inner cell mass of the fertilized
egg, which is pluripotent, and can be cultured indeﬁnitely in
an undifferentiated state and have the potential to
differentiate into three germ layer cell types. They have been
shown to give rise to functional hepatocytes that effectively
integrate into and replace injured parenchyma in many
devastating liver diseases. Deﬁnitive endoderm (DE) cells
are the precursors of both the liver and pancreas, and they
have to be induced to undergo hepatic and pancreatic dif-
ferentiation (Murry and Keller, 2008). Moreover, the expres-
sion of alpha fetal protein (AFP), albumin (ALB), and a biliary
molecular marker appear sequentially, suggesting the dif-
ferentiation of ESCs recapitulates the normal developmental
processes of the liver. There are some issues with these the
current differentiation protocols, including spontaneous dif-
ferentiation, low yield, the presence of undeﬁned and
xenogenetic compounds, necessity of cell sorting for speciﬁc
cell lineages, considerable enzymatic stress during repeated
culture (Haque et al., 2011) and cellular heterogeneity in the
culture (Nagaoka et al., 2008). Terminally speciﬁed cells of a
certain lineage represent only a minor cell fraction of the
differentiating ESCs in culture. Therefore, large-scale pro-
duction of highly puriﬁed cell lineages of interest is the
principle task of the ESC-based approach to regenerative
medicine. Potential therapeutic applications of ESC-Heps
are limited by their relatively low output in differentiating ESC
cultures and by the danger of contamination with tumori-
genic, undifferentiated ESCs. Furthermore, the use of ESCs
typically causes ethical and immunorejection issues, and the
elimination of these issues is critical for stem cell trans-































Figure 1. Liver regeneration is a rapidandwell-coordinatedprocess that requirescontributions frommultiplecell populations.
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Many studies have made substantial contributions to the
differentiation of ESCs into hepatocytes by continuously
improving inducers of differentiation and optimizing their
combinations and sequences (Li et al., 2010b; Liu et al.,
2010b; Wang et al., 2012; Zhang et al., 2013b). Most
induction methods try to imitate the routine embryonic
developmental process of the liver within a few days of
in vitro culture. Most of the induction processes are ineffec-
tive, complicated, time-consuming, expensive, and limited by
the difﬁculties involved in scaling up the procedures. Cyto-
chrome P (CYP) activity in human ESC-Heps was much
lower than in human primary hepatocytes cultured for 4 h
and was stable or increased for at least one week in culture,
which contrasts the observation of rapid loss of CYP activity
in cultured human primary hepatocytes (Ulvestad et al.,
2013). However, ESC-Heps are unable to function as efﬁ-
ciently as hepatoblasts or primary hepatocytes upon trans-
plantation in liver repopulation models. Clearly, improvement
of in vitro hepatic differentiation protocols and a better
understanding of the molecular mechanisms underlying liver
development are needed. Therefore, it can be speculated
that there are certain speciﬁc TFs, or a combination of TFs,
that can facilitate the differentiation of ESCs. Exposure of
adherent human ESCs in culture to activin A treatment fol-
lowed by various GFs, including dexamethasone, oncostatin
M, and HGF, results in the production of ESC-Heps that
possess hepatocyte-speciﬁc functions (Moore and Moghe,
2009). The signaling molecules bone morphogenic protein
(BMP) and FGF that have been implicated in hepatic differ-
entiation during normal embryonic development and have
been shown to play pivotal roles in generating hepatic cells
from DE cells derived from ESCs. Using a set of human adult
markers, including CAAT/enhancer binding protein
(C/EBPalpha), hepatocyte nuclear factor 4/7 ratio (HNF4al-
pha1/HNF4alpha7), CYP7A1, CYP3A4 and constitutive
androstane receptor, and fetal markers, including AFP,
CYP3A7, and glutathione S-transferase P1, by 21 days of
differentiation, ESC-Heps have the characteristics of fetal
hepatocytes at less than 20 weeks of gestation, but
extending the differentiation to 4 weeks does not improve
cell maturation (Funakoshi et al., 2011). Li et al. (Li et al.,
2011a) established an efﬁcient method for the induction of
mouse ESC-derived DE cells in suspension embryonic body
culture. The chemical activation of the canonical Wnt sig-
naling pathway synergized with the activin A-mediated nodal
signaling pathway to promote the induction of DE cells, and
inhibition of BMP4 signaling by Noggin and activin A further
improved the efﬁciency of DE cell differentiation. A combined
treatment with Wnt3a and BMP4 efﬁciently differentiated
human ESCs (Kim et al., 2013); after co-culture with STO
feeder cells, human ESCs were able to differentiate into
HLCs and cholangiocyte-like cells (Zhao et al., 2009).
Forkhead box A2 (Liu et al., 2013) and synthesized base-
ment membrane components (Shiraki et al., 2011) signiﬁ-
cantly increased the hepatic differentiation of ESCs.
Most studies demonstrating hepatic differentiation from
ESCs have been based on embryoid body (EB) formation,
aggregated colony formation in static culture. It has been
shown that dynamic three-dimensional perfusion culture is
superior to other culture systems for inducing maturation of
ESCs into fetal hepatocytes and prolonging the maintenance
of the hepatic functions of those cells. Ten pathways that were
signiﬁcantly upregulated in cells differentiated in a bioreactor
compared to cells grown in static culture were shown to be
highly related to liver functions (Sivertsson et al., 2013). The
differentiated phenotype was sustained for more than 2
weeks in the three-dimensional spheroid culture system,
which is signiﬁcantly longer than in monolayer culture
(Subramanian et al., 2014). EB-derived cells grown in a
rotating bioreactor exhibited higher levels of liver-speciﬁc
functions than those in static culture (Zhang et al., 2013a).
The hollow ﬁber/organoid culture method allows for cultured
ESCs to form an organoid, and the differentiating ESCs reach
a level of functionality comparable to or better than that of
primary mouse hepatocytes (Amimoto et al., 2011). Differen-
tiated cells grown on a biodegradable polymer scaffold and a
rotating bioreactor also exhibit morphologic traits and
biomarkers characteristic of liver cells (Wang et al., 2012).
Signiﬁcantly upregulated hepatic gene expression was
observed in the hepatic differentiation hollow ﬁber-based
three-dimensional perfusion bioreactors with integral oxy-
genation culture group (Miki et al., 2011). However, most of
the current three-dimensional differentiation conﬁgurations
involve interruptive operations during the multistaged differ-
entiation process, which might impose unwanted inﬂuence on
cellular differentiation. Off-the-shelf micro-stencil arrays were
developed to generate adherent multilayered colonies com-
posed of human ESC-derived cells; the microscaled multi-
layered colonies with uniform and deﬁned sizes constrained
within the microwells are composed of more homogenous and
mature HLCs with signiﬁcantly lowered AFP expression and
elevated hepatic functions (Yao et al., 2014). A combination of
co-culture with non-parenchymal liver cells and optimal GF
stimulation was found to induce endoderm and hepatic phe-
notypes earlier and to a much greater extent than GF arrays
or micropatterned co-cultures used individually (Tuleuova
et al., 2010). When coculturing ESCs with MLSgt20 cells,
which are derived from mesenchymal cells residing in murine
fetal livers, human ESC-derived AFP-producing cells dis-
played higher hepatocyte functions (Ishii et al., 2010). A
similar effect was observed in mouse ESCs co-cultured with
mouse HSCs as feeder cells in basal medium without addi-
tional hepatocyte growth factors (Chan et al., 2013).
Induced pluripotent stem cell-derived hepatocytes
(iPSC-Heps)
iPSCs were initially generated from terminally differentiated
adult cells using viral vectors for speciﬁc TFs, and later using
the non-integrating methods of treating cells with small
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molecules that affect methylation or acetylation, mimic the
Wnt-signaling pathway, or modulate the TGF-b pathway (Li
et al., 2009). These methods raised few ethical concerns
because of their derivation from somatic cells and, thus, are
powerful tools for studying basic developmental biology.
iPSCs are now considered to have the same level of
pluripotency as ESCs (Jia et al., 2010), and the mitochondria
of iPSCs were shown to act like those of ESCs by measuring
oxygen concentration and pH in hepatic induction medium,
which indicate the oxygen consumption rate and extracel-
lular acidiﬁcation rate, respectively (Tamai et al., 2011).
iPSCs can be differentiated into neural, osteogenic, cardiac,
adipogenic, pancreatic, vascular, hematopoietic, and
endothelial cells. In addition, they are potential sources of
hepatocytes for applications in regenerative medicine and
drug development (Noto et al., 2014). iPSCs from mouse
embryonic ﬁbroblasts and human ﬁbroblasts can be differ-
entiated into hepatic lineages with four reprogramming fac-
tors (Oct-4/Sox2/Klf-4/c-Myc) (Yamanaka and Blau, 2010). Li
et al. (Li et al., 2011b) demonstrated that iPSCs could be
differentiated into iPSC-Heps with biological functions with-
out being treated with c-Myc, and those iPSC-Heps reduced
the hepatic necrotic area and improved liver function. How-
ever, iPSCs in vivo are able to create chimeras by germ line
transmission and tetraploid complementation and form ter-
atomas containing various cell types from three embryonic
germ layers.
Liu et al. (Liu et al., 2010a) were the ﬁrst to reprogram
primary hepatocytes to pluripotency, and these hepatocyte-
derived iPSCs were able to directly differentiate into DE,
HPCs, and mature hepatocytes. The derivation of iPSCs
from somatic cells of patients with liver diseases, including
tyrosinemia, glycogen storage disease, progressive familial
hereditary cholestasis, and Crigler-Najjar syndrome (two
siblings), through retroviral transduction of Yamanaka’s fac-
tors in serum and feeder-free culture conditions has been
shown (Ghodsizadeh et al., 2010). Furthermore, those
iPSCs were efﬁciently differentiated into functional HLCs
(Ghodsizadeh et al., 2010). iPSCs are speciﬁed to primitive
streak/mesendoderm/deﬁnitive endoderm by sequential
stimulation with liver development-related cytokines, result-
ing in differentiated cells with characteristics of HLCs. CYP
activities in iPSC-Heps were stable or increased for at least
one week in culture, which contrasts with the rapid loss of
CYP activities in cultured human primary hepatocytes
between 4 h and 48 h after plating (Ulvestad et al., 2013).
iPSC-Heps can be directed to differentiate into HLCs by
mimicking embryonic and fetal liver development (Hannan
et al., 2013; Kajiwara et al., 2012; Takebe et al., 2013), but
most differentiated cells co-express AFP and ALB, sug-
gesting incomplete cell maturation. Although progress in
developing differentiation procedures has been made, it
remains challenging to generate iPSC-derived mature hep-
atocytes. Umeda et al. (Umeda et al., 2013) performed
knock-in of a monomeric Kusabira orange (mKO1) cassette
into the ALB gene in iPSCs with the use of a helper-
dependent adenovirus vector, and the ALB/mKo1 knock-in
iPSCs are valuable resources, as they show enhanced
in vitro hepatic differentiation function.
Compared with the in vivo environment of the liver, culture
conditions are relatively artiﬁcial, and this is likely to impact
the function of iPSC-Heps (Si-Tayeb et al., 2010). Activin has
the opposing effects of promoting differentiation into endo-
derm and maintaining pluripotency by regulating the
expression of Nanog (Shin et al., 2011). Dexamethasone
and insulin-transferrin-selenium are used to maintain the
in vitro functions of hepatocytes. In consideration of the
tedious differentiation work and complex combination of
cytokines, many investigators have focused on developing
concise and rapid methods for differentiating iPSCs into
HLCs. Chen et al. (Chen et al., 2012) established a rapid and
efﬁcient three-step differentiation protocol with HGF, activin
A, and Wnt3a that is able to generate functional HLCs from
human iPSCs. Then, Takata et al. (Takata et al., 2011)
described a two-step protocol for directing human iPSCs to
differentiate into hepatic cells using only two cytokines and a
short incubation time; furthermore, the differentiation efﬁ-
ciency of the two-step protocol was comparable to that of the
three-step protocol, and the induced hepatic cells were
functional. In the latest study by Tomizawa et al. (Tomizawa
et al., 2013), a single-step protocol for the differentiation of
iPSCs into hepatocytes was designed and involved expo-
sure to FoxA2, GATA4, HEX, and C/EBPα and culturing with
OERDITS supplementation. This protocol has the potential
to induce the differentiation of iPSCs into HLCs within 8
days. Kondo et al. (Kondo et al., 2014) developed a simple
method of differentiation of human iPSCs into functional
HLCs with small-molecule compounds, which are conve-
nient and inexpensive to obtain for large scale production
and do not have the potential to be contaminated with
exogenous viruses or cells. However, Zhang et al. (Zhang
et al., 2014) showed that human iPSC-derived mature HLCs
hardly ever proliferated in vitro, and in contrast, human
iPSC-derived hepatic endoderm cells exhibited a marked
proliferative capability.
All of the protocols discussed above are static culture
protocols for iPSCs, and three-dimensional culturing proto-
cols can signiﬁcantly enhance the function of HLCs. Hollow
ﬁber/organoid culture of mouse iPSCs to induce expression
of liver-speciﬁc genes and functions allows for spontaneous
differentiation with cell proliferation and self-organization,
high cell density, and the induction of differentiation in a large
number of cells (Amimoto et al., 2011). The micro-cavitary
hydrogel (MCG) system enhances nutrient exchange, per-
mits greater living space for the encapsulated pluripotent
stem cells to rapidly grow into colonies and results in sig-
niﬁcantly greater production of endoderm markers, hepatic
markers, urea, and ALB by iPSCs compared to the typical
non-MCG system, or monolayer culture (Lau et al., 2013).
Zhang et al. (Liu et al., 2013) reported three-dimensional
clump culture collagen matrices compatible with high
throughput screening resulted in signiﬁcantly increased
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functional maturation of iPSC-Heps towards an adult phe-
notype when compared to conventional culture systems.
Additionally, this approach spontaneously results in the
presence of polarized structures necessary for drug meta-
bolism and improves the functional longevity when culturing
in vitro over 75 days. Chiang et al. (Chiang et al., 2015)
reprogrammed human dental pulp-derived ﬁbroblasts into
iPSCs, developed an injectable carboxymethyl-hexanoyl
chitosan hydrogel (CHC) with sustained HGF release and
investigated the hepatoprotective activity of HGF-CHC-de-
livered iPSC-Heps in vitro. Compared with PBS-delivered
iPSC-Heps, the HGF-CHC-delivered iPSC-Heps exhibited
higher antioxidant and anti-apoptotic activities, which resul-
ted in a reduction of the hepatic necrotic area. Chien et al.
(Chien et al., 2015) demonstrated that embedment of
miR122 complexed with a polyurethane-graft-short-branch
polyethylenimine copolymer in nanostructured amphiphatic
carboxymethyl-hexanoyl chitosan led to dramatically enhanced
miR122 delivery into human dental pulp-derived iPSCs and
facilitated these cells to differentiate into iPSC-Heps with
mature hepatocyte functions.
Hepatic progenitor cell-derived hepatocytes (HPC-Heps)
The ﬁrst HPCs were identiﬁed by Farber (1956) and were
termed oval cells, a small bipotent cell type with a high
nuclear-to-cytoplasmic ratio, but in human it was deﬁned as
HPCs. They have been shown to emerge in several human
liver diseases, including primary biliary cirrhosis (Crosby
et al., 1998), primary sclerosing cholangitis (Vessey and de
la Hall, 2001), and hepatocellular adenoma (Libbrecht et al.,
2001). PH-activated progenitor cells are hepatic stem-like
cells that can be cultured in vitro for more than 3 months,
with the number of cells doubling 100 times over that period
(He et al., 2004). Human liver-derived stem cells can be
isolated and expanded from donated livers unsuitable for
transplantation and present a comparable morphology to
that of HSCs, which express a-smooth muscle actin,
vimentin, ﬁbronectin, CD73, and CD90 in accordance with
their mesenchymal origin (Berardis et al., 2014). They can
be induced to differentiate into cells with morphological,
phenotypic, and functional characteristics of mature hepa-
tocytes (He and Feng, 2011). Moreover, HPCs have a
greater regenerative capacity than adult hepatocytes and
participate in liver tissue repair and reconstruction following
injury. It has been reported that HPCs transplantation can be
used as a substitute for liver transplantation, and HPCs have
a deﬁnite therapeutic effect on patients with end-stage liver
diseases (Hughes et al., 2012). The effect of different PHs
and the duration of collagenase perfusion on hepatic stem
cell proliferation and differentiation varies; optimal differen-
tiation of hepatic stem cells to CK-18 and AFP-positive cells
was observed when stem cells isolated from 83.4% PH rats
were perfused with IV collagenase for 20 min (Gong et al.,
2013). Thy1 and CD44 oval and progenitor cells are able to
differentiate into hepatocytes, but the degree of maturation of
the induced hepatocytes may not be equal to that of healthy
resident hepatocytes (Ichinohe et al., 2013). Messenger
RNA expression levels of CYP1A2, CYP2B1/2, and CYP3A1
were higher in cells of young rats, and the proliferation and
differentiation potential of oval cells decreased with age
(Czekaj et al., 2010). Wang et al. (Wang et al., 2010)
demonstrated slight acceleration of proliferation of hepatic
oval cells after the 50th passage, but the cells remained
diploid with features of chromosomal stability. Furthermore,
they did not acquire anchorage-independent growth capacity
and did not develop into tumors in immunodeﬁcient mice,
suggesting that hepatic oval cells do not undergo sponta-
neous malignant transformation.
Current protocols for the differentiation of oval cells make
use of multiple treatments of soluble signals and/or matrix
factors and typically result in partial differentiation of oval
cells to mature cells with under- or over-expression of adult
tissue-speciﬁc genes. The activation of AKT, p70s6k, and
ERK1/2 induced by HGF in OC/CDE22 rat oval cells was
abolished by pretreatment with a phosphoinositide 3-OH
kinase inhibitor and a mitogen-activated protein kinase/ERK
kinase inhibitor, respectively (Okano et al., 2003). This
ﬁnding suggested that this signaling pathway is responsible
for the biological effect of HGF. LE/2 and LE/6 oval cells are
non-tumorigenic cells that were derived from the livers of
adult rats fed a choline-deﬁcient diet containing 0.1% ethio-
nin. After 4 weeks in a three-dimensional collagen gel matrix
and a ﬁbroblast feeder layer culture system, these cells
acquired typical hepatocytic morphology; however in the
absence of a feeder layer and in the presence of HGF and/or
keratinocyte growth factor, the precursor cells formed ductal
structures, suggestive of differentiation along the bile duct
lineage (Lazaro et al., 1998). The hepatic stem cell lines
HY1, HY2, and HY3, which were derived from healthy livers
of adult rats, showed an expression pattern similar to oval
cells and efﬁciently induced hepatic differentiation following
sequential treatment with type I collagen, TGF-b1, and HGF
or oncostatin M (Hirata et al., 2009). Human hepatic stem
cells seeded onto liver biomatrix scaffolds in a hormonally
deﬁned medium tailored for adult liver cells lost stem cell
markers and differentiated into mature, functional parenchy-
mal cells and remained viable with stable mature cell phe-
notypes for more than 8 weeks (Wang et al., 2011).
Mesenchymal stem cell-derived hepatocytes (MSC-Heps)
MSCs are highly proliferative, adherent mesenchymal cells
with a unique cell surface molecule expression proﬁle. The
differentiation potential of adult stem cells has long been
believed to be limited to the tissue or germ layer of their
origin. In addition to long-term self-renewal capability, MSCs
possess versatile differentiation potential ranging from
mesenchyme-related multipotency to neuroectodermal and
endodermal competency. Furthermore, they have the ability
to differentiate into a number of organ-speciﬁc cell types,
including hepatocytes (Christ and Dollinger, 2011). Adult
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stem cells can be derived from different tissues, such as
bone marrow, adipose, placenta, umbilical cord blood,
menstrual blood, and synovial tissues, etc.
When MSCs are treated with an external factor, their
differentiation ability may be improved. Cytokines may play a
more important role in the differentiation of MSCs into hep-
atocytes. When HGF, nicotinamide, or dexamethasone was
added to MSCs individually, incomplete hepatocyte differ-
entiation was achieved; the obtained cell populations con-
tained progenitors that expressed both hepatic (ALB) and
biliary (CK19) markers as well as AFP. When all factors were
added to the culture medium, the cells exhibited features that
closely resembled human adult hepatocytes (Chivu et al.,
2009). A combination of insulin-like growth factor-I and liver-
speciﬁc factors supported the potential development of
MSCs into primary hepatocytes (Ayatollahi et al., 2011), and
the addition of dimethylsulfoxide enhanced their differentia-
tion into hepatocytes (Seo et al., 2005). Alpha-1 antitrypsin
(AAT) deﬁciency is a hereditary disorder characterized by a
severe decrease in AAT plasma level, which leads to pro-
gressive liver dysfunction; however, human MSC-Heps can
be AAT genetically modiﬁed as a novel paradigm of coupling
cell therapy for this disease (Ghaedi et al., 2010). Acute
hepatic failure-derived bone marrow mesenchymal stem
cells (BMMSCs) have a hepatic transcriptional proﬁle,
express hepatocyte-speciﬁc genes early during differentia-
tion, and possess greater hepatogenic potency in vitro
compared to cells isolated from control animals (Li et al.,
2010a). Pretreatment of MSCs with injured liver tissue in an
in vitro model resulted in high expression of albumin, CK8,
CK18, transaminase, and HNF1a compared to untreated
MSCs, indicating that this pretreatment augmented the
homing and hepatic differentiation abilities of MSCs (Mohsin
et al., 2011). Culturing in hepatocyte-conditioned medium
without any cytokines can induce the differentiation of
BMMSCs into HLCs (Chen et al., 2007). Quiescent HSCs or
culture-activated HSCs do not have the ability to modulate
the differentiation of MSCs. Moreover, Kupffer cell-activated
HSCs expressed HGF mRNA, and culture-activated HSCs
did not (Deng et al., 2008).
MSCs grown on nanoﬁbers showed enhanced differenti-
ation into HLCs and maintained their function in long-term
culture; hepatocyte markers ALB and HNF4α were elevated
in a time-dependent manner, and CYP450 enzymes were
signiﬁcantly increased in the HLCs differentiated in vitro from
MSCs grown on nanoﬁbers at day 36 (Piryaei et al., 2011).
BMMSCs cultured in alginate scaffolds in the presence of
speciﬁc GFs display several liver-speciﬁc markers and
functions (Lin et al., 2010). A three-dimensional co-culture
system of porcine hepatocytes and BMMSCs was estab-
lished in vitro, and the best hepatic function levels were
achieved on day 2 and moderately decreased in the fol-
lowing co-culture days (Gu et al., 2009). Culturing human
adipose-derived mesenchymal stem cells (ADMSCs) on top
of HGF/Col spots (HGF co-printed with collagen I to create
arrays of protein spots on glass) for 2 weeks can differentiate
them into HLCs (Ghaedi et al., 2011). Floating culture efﬁ-
ciently induced human ADMSCs into functional HLCs in vitro
(Okura et al., 2010).
FUTURE DIRECTIONS
The liver regeneration process has been evaluated in PH
models. Although it has been studied extensively, many
important fundamental mechanisms remain undeﬁned, such
as the mechanisms of cellular hypertrophy, cell division,
nuclear division, ploidy changes, and organ size control. The
current shortage of donor organs available for live transplan-
tation and the severe morbidity and mortality associated with
this procedure underscores the need for alternatives to liver
transplantation. In vivo hepatocytes proliferate to repair
injured liver tissue, but this process is too complex to mimic
in vitro to obtain functional hepatocytes. Culture methods for
the enhancement of isolated primary hepatocytes or HLCs
in vitro include the addition of GFs, TFs, and cytokines, the
activation of signaling pathways, the use of an optimized
matrix, and co-culture with various nonparenchymal cells. All
of these methods are able to improve the function of primary
hepatocytes or HLCs in vitro to a certain extent, but unfortu-
nately, the amount of available mature hepatocytes have
been insufﬁcient for clinical use in the past several decades.
And the lack of standardization of protocols for isolating
speciﬁc cell types and the use of a variety of injury/disease
models have made the interpretation of these results rather
difﬁcult and have left unanswered questions regarding the
mechanisms through which these cells generate their bene-
ﬁcial effects.
The observed effects of cell therapies for liver regenera-
tion have certainly generated reserved optimism toward their
value for clinical use once the methodologies have become
standardized and optimized. With clariﬁcation of the process
of liver regeneration, hepatocytes or HLCs that can grow and
proliferate persistently and functionally in vitro and in vivo will
be able to be used to fulﬁll the needs of injured livers for
regeneration, and cell transplantation and artiﬁcial liver
support will completely replace liver transplantation.
ABBREVIATIONS
AAT, alpha-1 antitrypsin; ADMSCs, adipose derived mesenchymal
stem cells; AFP, alpha fetal protein; ALB, albumin; BMMSCs, bone
marrow mesenchymal stem cells; BMP, bone morphogenic protein;
CHC, carboxymethyl-hexanoyl chitosan hydrogel; CYP, cytochrome
P; DE, deﬁnitive endoderm; EB, embryoid bodies; ECM, extracel-
lular matrix; ESC, embryonic stem cell; ESC-Heps, embryonic stem
cell-derived hepatocytes; FGF, ﬁbroblast growth factor; GFs, growth
factors; HLCs, hepatocyte-like cells; HPC, hepatic progenitor cell;
HPC-Heps, hepatic progenitor cell-derived hepatocytes; HSCs,
hepatic stellate cells; IL, interleukin; iPSC, induced pluripotent stem
cell; iPSC-Heps, induced pluripotent stem cell-derived hepatocytes;
MCG, micro-cavitary hydrogel; mKO1, monomeric Kusabira orange;
MSC, mesenchymal stem cell; MSC-Heps, mesenchymal stem cell-
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derived hepatocytes; PH, partial hepatectomy; SHs, small hepato-
cyte-like progenitor cells; TFs, transcription factors.
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